Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Presage Biosciences, Inc.

1 abstract

Abstract
Multiplexed trackable intratumor microdosing of the investigational STING agonist TAK-676 alone and in combination in the native tumor microenvironment of patients with head and neck cancer: A phase 0 trial.
Org: Presage Biosciences, Inc., Takeda Pharmaceuticals U.S.A., Inc.,